CPHL · Citi Pharma Ltd.
Board Meeting
- Filed
- 28 September 2026 at 8:31 am
- Category
- Meetings
- Sentiment
- Neutral
- Impact
- Low
AI executive summary
Citi Pharma Limited has announced a meeting of its Board of Directors scheduled for October 03, 2026, to consider the Annual Audited Financial Statements for the year ended June 30, 2026. A closed period has been declared from September 27, 2026, to October 03, 2026.
Key takeaways
- Board meeting scheduled for October 03, 2026 at 14:00 PST
- Purpose is to consider annual financial results for the period ended June 30, 2026
- Closed period in effect from September 27, 2026 to October 03, 2026
Filing details
Board meeting
- Status
- Scheduled
- Meeting date
- 3 October 2026 at 2:00 pm
- Purpose
- Consider the Annual Audited Financial Statements for the year ended June 30, 2026
- Venue
- Head office situated at 588, Q-Block, Johar Town, Lahore, Lahore
- Closed period
- 27 September 2026 – 3 October 2026
- Consider and approve the Annual Audited Financial Statements of the Company for the year ended June 30, 2026
- Transact any other business with the permission of the Chair
- #board meeting
- #financial results
- #annual accounts
- #closed period
This summary is AI-generated and may contain errors or omissions. Review the official PSX filing before making an investment decision.